David Lu
University of Pennsylvania(US)
Publications by Year
Research Areas
Cancer Cells and Metastasis, Prostate Cancer Treatment and Research, Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Radiopharmaceutical Chemistry and Applications
Most-Cited Works
- → Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer(2016)632 cited
- → Assessment of the Validity of Nuclear-Localized Androgen Receptor Splice Variant 7 in Circulating Tumor Cells as a Predictive Biomarker for Castration-Resistant Prostate Cancer(2018)237 cited
- → Nuclear-specific AR-V7 Protein Localization is Necessary to Guide Treatment Selection in Metastatic Castration-resistant Prostate Cancer(2016)182 cited
- → Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate Cancer(2017)135 cited
- → Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients(2016)105 cited
- → Baicalein upregulates DDIT4 expression which mediates mTOR inhibition and growth inhibition in cancer cells(2014)91 cited
- → Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse Survival(2017)71 cited
- → The EGFR Exon 19 Mutant L747-A750>P Exhibits Distinct Sensitivity to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma(2019)60 cited
- → Biochemical and structural basis for differential inhibitor sensitivity of EGFR with distinct exon 19 mutations(2022)38 cited
- → Beta Adrenergic Control of Extrarenal Potassium Disposal(1986)28 cited